Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.
OBJECTIVE
To evaluate the prognostic value of the proliferative factors, MIB-1 index, DNA ploidy, and S-phase fraction, and further to determine the independent prognostic factors in ampulla of Vater carcinoma after pancreaticoduodenectomy.


BACKGROUND
Cell kinetics are important indicators of the biologic behavior of various human tumors, but only a few authors have reported the application of cell proliferative factors in ampulla of Vater carcinoma.


METHODS
Patients undergoing pancreaticoduodenectomy for ampulla of Vater carcinoma were included. Proliferative factors, MIB-1 index, and DNA contents, measured by flow cytometry, were evaluated and compared with the conventional clinicopathologic factors.


RESULTS
Ninety resectable ampulla of Vater carcinomas were included. By univariate analysis, MIB-1 index, DNA ploidy, S-phase fraction, stage, and lymph node status were significant prognostic factors. The 5-year survival rate was 40.7% for tumors with MIB-1 index < or =15% and 0% for those with MIB-1 index >15%. Diploid tumors had a significantly better prognosis than aneuploid. Outcomes of stage I and II tumors were more favorable than those of stage III and IV. After multivariate analysis, MIB-1 index, DNA ploidy, and stage remained as the independent prognostic factors. Among the three independent prognostic factors, MIB-1 index was the most powerful.


CONCLUSIONS
Both MIB-1 index and DNA ploidy provide important prognostic value and potentially complement the conventional prognostic factors in resectable ampulla of Vater carcinoma. MIB-1 index is the most powerful independent prognostic factor.
Shyr
Y M
YM
Department of Surgery, Veterans General Hospital-Taipei, National Yang Ming University, Taiwan, Republic of China.
Su
C H
CH
Wu
L H
LH
Li
A F
AF
Chiu
J H
JH
Wu
C W
CW
Lui
W Y
WY
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014670:Ampulla of Vater; D034961:Antigens, Nuclear; D015415:Biomarkers / Q000032:analysis; D002277:Carcinoma / Q000737:chemistry / Q000235:genetics / Q000401:mortality* / Q000473:pathology / Q000601:surgery*; D003138:Common Bile Duct Neoplasms / Q000737:chemistry / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D019394:Ki-67 Antigen; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D009687:Nuclear Proteins / Q000032:analysis; D016577:Pancreaticoduodenectomy; D011003:Ploidies; D011379:Prognosis; D016196:S Phase; D015996:Survival Rate
D034961:Antigens, Nuclear; D015415:Biomarkers; D019394:Ki-67 Antigen; D009687:Nuclear Proteins